BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35007407)

  • 1. Targeting the Meningeal Compartment to Resolve Chemobrain and Neuropathy via Nasal Delivery of Functionalized Mitochondria.
    Alexander JF; Mahalingam R; Seua AV; Wu S; Arroyo LD; Hörbelt T; Schedlowski M; Blanco E; Kavelaars A; Heijnen CJ
    Adv Healthc Mater; 2022 Apr; 11(8):e2102153. PubMed ID: 35007407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits.
    Alexander JF; Seua AV; Arroyo LD; Ray PR; Wangzhou A; Heiβ-Lückemann L; Schedlowski M; Price TJ; Kavelaars A; Heijnen CJ
    Theranostics; 2021; 11(7):3109-3130. PubMed ID: 33537077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice.
    Boukelmoune N; Laumet G; Tang Y; Ma J; Mahant I; Singh SK; Nijboer C; Benders M; Kavelaars A; Heijnen CJ
    Brain Behav Immun; 2021 Mar; 93():43-54. PubMed ID: 33316379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the A
    Singh AK; Mahalingam R; Squillace S; Jacobson KA; Tosh DK; Dharmaraj S; Farr SA; Kavelaars A; Salvemini D; Heijnen CJ
    Acta Neuropathol Commun; 2022 Jan; 10(1):11. PubMed ID: 35093182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
    Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
    Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice.
    Chiu GS; Boukelmoune N; Chiang ACA; Peng B; Rao V; Kingsley C; Liu HL; Kavelaars A; Kesler SR; Heijnen CJ
    Oncotarget; 2018 Oct; 9(85):35581-35597. PubMed ID: 30473752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice.
    Huo X; Reyes TM; Heijnen CJ; Kavelaars A
    Sci Rep; 2018 Nov; 8(1):17400. PubMed ID: 30479361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.
    Ma J; Huo X; Jarpe MB; Kavelaars A; Heijnen CJ
    Acta Neuropathol Commun; 2018 Oct; 6(1):103. PubMed ID: 30270813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment.
    Milutinovic B; Mahalingam R; Mendt M; Arroyo L; Seua A; Dharmaraj S; Shpall E; Heijnen CJ
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
    Park HS; Kim CJ; Kwak HB; No MH; Heo JW; Kim TW
    Neuropharmacology; 2018 May; 133():451-461. PubMed ID: 29477301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice.
    Zhou W; Kavelaars A; Heijnen CJ
    PLoS One; 2016; 11(3):e0151890. PubMed ID: 27018597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pifithrin-μ Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function.
    Chiu GS; Maj MA; Rizvi S; Dantzer R; Vichaya EG; Laumet G; Kavelaars A; Heijnen CJ
    Cancer Res; 2017 Feb; 77(3):742-752. PubMed ID: 27879267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice.
    Chiang ACA; Seua AV; Singhmar P; Arroyo LD; Mahalingam R; Hu J; Kavelaars A; Heijnen CJ
    Acta Neuropathol Commun; 2020 Nov; 8(1):193. PubMed ID: 33183353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.
    Ma J; Kavelaars A; Dougherty PM; Heijnen CJ
    Cancer; 2018 Jun; 124(11):2289-2298. PubMed ID: 29461625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo.
    El-Derany MO; Noureldein MH
    Stem Cell Res Ther; 2021 Jun; 12(1):322. PubMed ID: 34090498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HDAC6 inhibitor reverses chemotherapy-induced mechanical hypersensitivity via an IL-10 and macrophage dependent pathway.
    Zhang J; Ma J; Trinh RT; Heijnen CJ; Kavelaars A
    Brain Behav Immun; 2022 Feb; 100():287-296. PubMed ID: 34915156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
    Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
    Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function.
    Rashid MA; Tang JJ; Yoo KH; Corujo-Ramirez A; Oliveros A; Kim SH; Ullah F; Altawell R; Hawse JR; Cole PD; Jang MH
    Front Mol Neurosci; 2023; 16():1295991. PubMed ID: 38095013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in the elucidation of the mechanisms of chemotherapy-induced cognitive impairment.
    Alhowail AH; Aldubayan M
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5807-5817. PubMed ID: 34604972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Reduction of Mitochondria Complex I Subunits is Protective against Cisplatin-Induced Neurotoxicity in
    Groen CM; Podratz JL; Pathoulas J; Staff N; Windebank AJ
    J Neurosci; 2022 Feb; 42(5):922-937. PubMed ID: 34893548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.